香雪製藥(300147.SZ)主打產品抗病毒口服液被政府列入疫情防控藥品並承擔儲備任務
格隆匯2月3日丨香雪製藥(300147.SZ)公佈,公司股票交易價格於2020年1月23日、2月3日連續兩個交易日收盤價格漲幅偏離值累計超過20%,達到了深圳證券交易所相關規則規定的異常波動標準。公司股價短期波動幅度較大,敬請廣大投資者注意二級市場交易風險,理性決策,審慎投資。
經公司自查並向公司實際控制人核實,截至公告披露日,除公司已披露事項外,不存在應披露而未披露的重大信息。
自新型冠狀病毒肺炎疫情發生以來,引起了社會廣泛關注。公司主打產品抗病毒口服液被政府列入疫情防控藥品並承擔儲備任務,香雪抗病毒口服液是醫務工作者及患者的一線預防用藥,市場對公司抗病毒口服液需求激增,公司積極響應黨中央習近平總書記的重要指示,把人民羣眾生命安全和身體健康放在第一位,切實做好保障人民羣眾生命安全、身體健康及醫療的需要。公司全力以赴趕產,儘量滿足疫情及人民羣眾的用藥需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.